India's Pharmaceutical Exports

Country Profile

Guinea-Bissau

Guinea-Bissau is a developing market for Indian pharmaceuticals — $2.63M in FY 2025–26, with 3.0× growth over the past decade. Medicines accounts for 95% of shipments, with vaccines contributing $102K. The compound annual growth rate since FY2015 stands at 10.5%.

🇬🇼 $2.63M · 3.0× growth since FY2015 · 10.5% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$2.63M
Exports FY2025–26 DGCIS
3.0×
Growth FY2015→2026
10.5%
CAGR FY2015→2026
95%
Medicines Share
3
Product Categories Supplied
Guinea-Bissau is a developing market for Indian pharmaceuticals — $2.63M in FY 2025–26, with 3.0× growth over the past decade. Medicines accounts for 95% of shipments, with vaccines contributing $102K. The compound annual growth rate since FY2015 stands at 10.5%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $2.49M (94.7%) Vaccines $102K (3.9%) Surgical & Hospital Supplies $37K (1.4%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Guinea-Bissau in the RBI overseas direct investment dataset (2011–2026).